160 related articles for article (PubMed ID: 10609509)
21. Breast cancer metastatic to uterine leiomyoma: a case report.
Sugiyama T; Toyoda N; Nose J; Kihira N; Ando Y; Ishihara A
J Obstet Gynaecol (Tokyo 1995); 1995 Aug; 21(4):349-55. PubMed ID: 8775904
[TBL] [Abstract][Full Text] [Related]
22. [Receptor (ER, PgR) levels as prognostic factors in the endocrine therapy of pre- and post-menopausal patients with stage III infiltrative ductal and lobular cancer of the breast].
Calzada L; Salazar EL; Pedron Nuevo N
Ginecol Obstet Mex; 1996 Mar; 64():135-9. PubMed ID: 8729191
[TBL] [Abstract][Full Text] [Related]
23. Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen.
Meattini I; Livi L; Saieva C; Franceschini D; Scotti V; Mangoni M; Loi M; Di Brina L; Zei G; Bonomo P; Greto D; Gelain E; Nori J; Sanchez LJ; Orzalesi L; Bianchi S; Biti G
Clin Breast Cancer; 2013 Aug; 13(4):247-53. PubMed ID: 23684167
[TBL] [Abstract][Full Text] [Related]
24. Lobular carcinoma metastasis to endometrial polyp unrelated to tamoxifen. Report of a case and review of the literature.
Manipadam MT; Walter NM; Selvamani B
APMIS; 2008 Jun; 116(6):538-40. PubMed ID: 18754330
[TBL] [Abstract][Full Text] [Related]
25. Lobular carcinoma of the breast metastatic to the uterus in a patient under adjuvant anastrozole therapy.
Erkanli S; Kayaselcuk F; Kuscu E; Bolat F; Sakalli H; Haberal A
Breast; 2006 Aug; 15(4):558-61. PubMed ID: 16311034
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Stitt L
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):117-23. PubMed ID: 9747828
[TBL] [Abstract][Full Text] [Related]
27. [Expansive uterine myoma during tamoxifen therapy. 11 cases].
Le Bouëdec G; de Latour M; Dauplat J
Presse Med; 1995 Nov; 24(36):1694-6. PubMed ID: 8545398
[TBL] [Abstract][Full Text] [Related]
28. Metastasis of lobular breast carcinoma to the cervix.
Perisić D; Jancić S; Kalinović D; Cekerevac M
J Obstet Gynaecol Res; 2007 Aug; 33(4):578-80. PubMed ID: 17688635
[TBL] [Abstract][Full Text] [Related]
29. Carcinoid tumor of the uterine corpus. A case report.
González-Bosquet E; González-Bosquet J; García Jiménez A; Gil A; Xercavins J
J Reprod Med; 1998 Sep; 43(9):844-6. PubMed ID: 9777628
[TBL] [Abstract][Full Text] [Related]
30. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
Hauth E; Libera H; Kimmig R; Forsting M
Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
[TBL] [Abstract][Full Text] [Related]
31. Leiomyoma of the breast in a 50-year-old woman receiving tamoxifen.
Son EJ; Oh KK; Kim EK; Son HJ; Jung WH; Lee HD
AJR Am J Roentgenol; 1998 Dec; 171(6):1684-6. PubMed ID: 9843313
[No Abstract] [Full Text] [Related]
32. Papillary-serous adenocarcinoma of the uterine cervix during tamoxifen therapy after bilateral breast cancer.
Watrowski R; Striepecke E; Jäger C; Bauknecht T; Horst C
Anticancer Res; 2012 Nov; 32(11):5075-8. PubMed ID: 23155282
[TBL] [Abstract][Full Text] [Related]
33. Synchronous metastasis from lobular carcinoma and primary carcinoma of the endometrium in a patient after tamoxifen therapy.
Vicioso L; Ortega MV; Cívico V; López-Beltrán A
Int J Gynecol Pathol; 2013 Jan; 32(1):66-70. PubMed ID: 23202785
[TBL] [Abstract][Full Text] [Related]
34. Abnormal uterine bleeding as a presentation of metastatic breast disease in a patient with advanced breast cancer on tamoxifen therapy.
Famoriyo A; Sawant S; Banfield PJ
Arch Gynecol Obstet; 2004 Nov; 270(3):192-3. PubMed ID: 14735373
[TBL] [Abstract][Full Text] [Related]
35. High-grade endometrial stromal sarcoma after tamoxifen therapy for breast cancer.
Sesti F; Patrizi L; Ermini B; Palmieri G; Orlandi A; Piccione E
Gynecol Obstet Invest; 2005; 60(2):117-20. PubMed ID: 15920338
[TBL] [Abstract][Full Text] [Related]
36. Endometrioid carcinoma in pelvic endometriosis in a postmenopausal woman with tamoxifen adjuvant therapy for breast cancer. A case report.
Bardi M; Arnoldi E; Pizzocchero G; Pezzica E; Mattioni D; Perotti M
Eur J Gynaecol Oncol; 1994; 15(5):393-5. PubMed ID: 7828611
[TBL] [Abstract][Full Text] [Related]
37. G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer.
Ignatov A; Ignatov T; Weissenborn C; Eggemann H; Bischoff J; Semczuk A; Roessner A; Costa SD; Kalinski T
Breast Cancer Res Treat; 2011 Jul; 128(2):457-66. PubMed ID: 21607586
[TBL] [Abstract][Full Text] [Related]
38. Metastatic breast lobular carcinoma to tamoxifen-associated endometrial polyp: case report and literature review.
Al-Brahim N; Elavathil LJ
Ann Diagn Pathol; 2005 Jun; 9(3):166-8. PubMed ID: 15944961
[TBL] [Abstract][Full Text] [Related]
39. Development of uterine sarcoma after tamoxifen treatment for breast cancer: report of four cases.
Yildirim Y; Inal MM; Sanci M; Yildirim YK; Mit T; Polat M; Tinar S
Int J Gynecol Cancer; 2005; 15(6):1239-42. PubMed ID: 16343223
[TBL] [Abstract][Full Text] [Related]
40. Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial.
Jirström K; Rydén L; Anagnostaki L; Nordenskjöld B; Stål O; Thorstenson S; Chebil G; Jönsson PE; Fernö M; Landberg G
J Clin Pathol; 2005 Nov; 58(11):1135-42. PubMed ID: 16254100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
